Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Ellner

Showing results (221-230 of 228) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 228 results.
American Journal of Respiratory and Critical Care Medicine|April 14, 2000
Predicting the outcome of therapy for pulmonary tuberculosisR S Wallis, M D Perkins, M Phillips, et al.
The Journal of Infectious Diseases|November 7, 1998
Induction of the antigen 85 complex of Mycobacterium tuberculosis in sputum: a determinant of outcome in pulmonary tuberculosis treatmentR S Wallis, M Perkins, M Phillips, et al.
The Journal of Infectious Diseases|April 8, 2000
Randomized controlled trial of Mycobacterium vaccae immunotherapy in non-human immunodeficiency virus-infected ugandan adults with newly diagnosed pulmonary tuberculosis. The Uganda-Case Western Reserve University Research CollaborationJ L Johnson, R M Kamya, A Okwera, et al.
Journal of Clinical Microbiology|August 31, 2002
Mycobacterium africanum subtype II is associated with two distinct genotypes and is a major cause of human tuberculosis in Kampala, UgandaS Niemann, S Rüsch-Gerdes, M L Joloba, et al.
AIDS (London, England)|January 6, 1999
A phase II/III trial of antimicrobial therapy with or without amikacin in the treatment of disseminated Mycobacterium avium infection in HIV-infected individuals. AIDS Clinical Trials Group Protocol 135 Study TeamD M Parenti, P L Williams, R Hafner, et al.
Antimicrobial Agents and Chemotherapy|October 30, 1999
Drug tolerance in Mycobacterium tuberculosisR S Wallis, S Patil, S H Cheon, et al.
AIDS (London, England)|October 31, 2001
Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adultsJ L Johnson, A Okwera, D L Hom, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 11, 2025
Impact of premorbid nutritional status on TB severityA Tabackman, A N Gupte, B Thangakunam, et al.
Pageof 23

Showing results (221-230 of 228) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 228 results.
American Journal of Respiratory and Critical Care Medicine|April 14, 2000
Predicting the outcome of therapy for pulmonary tuberculosisR S Wallis, M D Perkins, M Phillips, et al.
The Journal of Infectious Diseases|November 7, 1998
Induction of the antigen 85 complex of Mycobacterium tuberculosis in sputum: a determinant of outcome in pulmonary tuberculosis treatmentR S Wallis, M Perkins, M Phillips, et al.
The Journal of Infectious Diseases|April 8, 2000
Randomized controlled trial of Mycobacterium vaccae immunotherapy in non-human immunodeficiency virus-infected ugandan adults with newly diagnosed pulmonary tuberculosis. The Uganda-Case Western Reserve University Research CollaborationJ L Johnson, R M Kamya, A Okwera, et al.
Journal of Clinical Microbiology|August 31, 2002
Mycobacterium africanum subtype II is associated with two distinct genotypes and is a major cause of human tuberculosis in Kampala, UgandaS Niemann, S Rüsch-Gerdes, M L Joloba, et al.
AIDS (London, England)|January 6, 1999
A phase II/III trial of antimicrobial therapy with or without amikacin in the treatment of disseminated Mycobacterium avium infection in HIV-infected individuals. AIDS Clinical Trials Group Protocol 135 Study TeamD M Parenti, P L Williams, R Hafner, et al.
Antimicrobial Agents and Chemotherapy|October 30, 1999
Drug tolerance in Mycobacterium tuberculosisR S Wallis, S Patil, S H Cheon, et al.
AIDS (London, England)|October 31, 2001
Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adultsJ L Johnson, A Okwera, D L Hom, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 11, 2025
Impact of premorbid nutritional status on TB severityA Tabackman, A N Gupte, B Thangakunam, et al.
Pageof 23